Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis

Gene targeting of Cdc42 GTPase has been shown to inhibit platelet activation. In this study, we investigated a hypothesis that inhibition of Cdc42 activity by CASIN, a small molecule Cdc42 Activity-Specific INhibitor, may down regulate platelet activation and thrombus formation. We investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xin, Perveen, Rehana, Dandamudi, Akhila, Adili, Reheman, Johnson, James, Funk, Kevin, Berryman, Mark, Davis, Ashley Kuenzi, Holinstat, Michael, Zheng, Yi, Akbar, Huzoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222210/
https://www.ncbi.nlm.nih.gov/pubmed/34162972
http://dx.doi.org/10.1038/s41598-021-92654-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222210/
https://www.ncbi.nlm.nih.gov/pubmed/34162972
http://dx.doi.org/10.1038/s41598-021-92654-6

Ejemplares similares